Dihydroergotamine injection and Insulin glulisine Subcutaneous
Determining the interaction of Dihydroergotamine injection and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine injection-Insulin human inhaled Inhalation
- Dihydroergotamine injection-Insulin human regular Injection
- Dihydroergotamine injection-Insulin inhalation
- Dihydroergotamine injection-Insulin isophane
- Dihydroergotamine injection-Insulin isophane and insulin regular
- Dihydroergotamine injection-Insulin lispro
- Insulin glulisine Subcutaneous-Dihydroergotamine Mesylate
- Insulin glulisine Subcutaneous-Dihydroergotamine nasal
- Insulin glulisine Subcutaneous-Dihydroergotamine Nasal Spray
- Insulin glulisine Subcutaneous-Dilacor XR
- Insulin glulisine Subcutaneous-Dilantin
- Insulin glulisine Subcutaneous-Dilantin Infatabs